CostertonJW, StewartPS, GreenbergEP. Bacterial biofilms: A common cause of persistent infections. Science1999;284(5418):1318–22.
2.
BuretA, WardKH, OlsonME, CostertonJW. An in vivo model to study the pathobiology of infectious biofilms on biomaterial surfaces. J Biomed Mater Res1991;25(7):865–74.
3.
GilbertP, CollierPJ, BrownMR. Influence of growth rate on susceptibility to antimicrobial agents: Biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother1990;34(10):1865–8.
4.
HoyleBD, JassJ, CostertonJW. The biofilm glycocalyx as a resistance factor. J Antimicrob Chemother1990;26(1):1–5.
5.
OlsonME, CeriH, MorckDW, Biofilm bacteria: Formation and comparative susceptibility to antibiotics. Can J Vet Res2002;66(2):86–92.
6.
DesrosiersM, BendouahZ, BarbeauJ.Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro. Am J Rhinol2007;21(2):149–53.
7.
ChiuAG, AntunesMB, PalmerJN, CohenNA. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms. J Antimicrob Chemother2007;59(6):1130–4.
8.
VaudauxP, FrancoisP, Berger-BächiB, LewDP. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in aglycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.J Antimicrob Chemother2001;47(2):163–70.
9.
ChenHY, YuanM, LivermoreDM. Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J Med Microbiol1995;43(4):300–9.
10.
BroounA, LiuS, LewisK.A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother2000;44(3):640–6.
11.
GiwercmanB, JensenET, HøibyN, Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob Agents Chemother1991;35(5):1008–10.
12.
PeronDL, KitamuraK, CarniolPJ, SchuknechtHF. Clinical and experimental results with focused ultrasound. Laryngoscope1983;93(9):1217–21.
13.
MorizonoT, SikoraMA. The ototoxicity of topically applied povidone-iodine preparations. Arch Otolaryngol1982;108(4):210–13.
14.
PostJC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope2001;111(12):2083–94.
15.
WalkerTS, TomlinKL, WorthenGS, Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun2005;73(6):3693–3701.
16.
Jensen PØ, BjarnsholtT, PhippsR, Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa.Microbiology2007;153(Pt 5):1329–38.
17.
AlperCM, DoharJE, GulhanM, Treatment of chronic suppurative otitis media with topical tobramycin and dexamethasone. Arch Otolaryngol Head Neck Surg2000;126(2):165–73.
18.
RolandPS, KreislerLS, ReeseB, Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics2004;113(1 Pt 1):e40–6.
19.
RolandPS, DoharJE, LanierBJ, ; CIPRODEX AOMT Study Group. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of granulation tissue in children with acute otitis media with otorrhea through tympanostomy tubes. Otolaryngol Head Neck Surg2004:130(6):736–41.
20.
RolandPS, AnonJB, MoeRD, Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope2003;113(12):2116–22.
21.
van BalenFA, SmitWM, ZuithoffNP, VerheijTJ. Clinical efficacy of three common treatments in acute otitis externa in primary care: Randomised controlled trial. BMJ2003;327(7425):1201–5.
22.
TsikoudasA, JasserP, EnglandRJ. Are topical antibiotics necessary in the management of otitis externa? Clin Otolaryngol Allied Sci2002;27(4):260–2.
23.
AnwarH, StrapJL, ChenK, CostertonJ W.Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother1992;36(6):1208–14.
24.
MalatyJ, AntonelliPJ. Effect of body fluids on tympanostomy tube biofilm formation with Pseudomonas aeruginosa. Submitted for presentation at the Southern Section meeting of the Triological Society; January 2008; Naples, Fla.
25.
KinnariTJ, SalonenEM, JeroJ.Durability of the binding inhibition of albumin coating on tympanostomy tubes. Int J Pediatr Otorhinolaryngol2003;67(2):157–64.
BerryJA, BiedlingmaierJF, WhelanPJ. In vitro resistance to bacterial biofilm formation on coated fluoroplastic tympanostomy tubes. Otolaryngol Head Neck Surg2000;123(3):246–51.
28.
LoefflerKA, JohnsonTA, BurneRA, AntonelliPJ. Biofilm formation in an in vitro model of cochlear implants with removable magnets. Otolaryngol Head Neck Surg2007;136(4):583–8.
29.
JohnsonTA, LoefflerTA, BurneRA, Biofilm formation in cochlear implants with cochlear drug delivery channels in an in vitro model. Otolaryngol Head Neck Surg2007;136(4):577–82.
30.
PasmoreM, ToddP, SmithS, Effects of ultrafiltration membrane surface properties on Pseudomonas aeruginosa biofilm initiation for the purpose of reducing biofouling. Journal of Membrane Science2001;194(1):15–32.
31.
ScheuermanTR, CamperAK, HamiltonMA. Effects of substratum topography on bacterial adhesion. J Colloid Interface Sci1998;208(1):23–33.
32.
ChungK, SchumacherJ, SampsonE, Engineered substratum topography to disrupt bacterial biofilm formation. Presented at the 32nd annual meeting of the Society for Biomaterials; April 18–21, 2007; Chicago.
33.
BothwellMR, SmithAL, PhillipsT.Recalcitrant otorrhea due to Pseudomonas biofilm. Otolaryngol Head Neck Surg2003;129(5):599–601.
34.
TatarEC, UnalFO, TatarI, Investigation of surface changes in different types of ventilation tubes using scanning electron microscopy and correlation of findings with clinical follow-up. Int J Pediatr Otorhinolaryngol2006;70(3):411–17.
35.
MehtaAJ, LeeJC, StevensGR, AntonelliPJ. Opening plugged tympanostomy tubes: Effect of biofilm formation. Otolaryngol Head Neck Surg2006;134(1):121–5.